OR WAIT null SECS
Center for Drug Evaluation and Research, FDA
Andre Raw, PhD is with the Center for Drug Evaluation and Research, FDA
September 02, 2016
Companies may potentially accelerate the approval of generic drugs by avoiding deficiencies in ANDA submissions.
September 01, 2015
An analysis of controlled correspondence between generic-drug manufacturers and FDA reveals patterns in questions about specific drug chemistry topics and the response to information provided in FDA guidance documents.